Recent years have brought notable progress in osteoporosis treatments, including bisphosphonates, Selective Estrogen Receptor Modulators (SERMs), calcitonin, and parathyroid hormone (PTH) and its analogs, along with the newer Sclerostin inhibitors (4, 5). Here, SOST is linked to osteoporosis.